Biology of Blood and Marrow Transplantation
Volume 15, Issue 11 , Pages 1400-1406 , November 2009

Minor ABO-Mismatches are Risk Factors for Acute Graft-versus-Host Disease in Hematopoietic Stem Cell Transplant Patients

  • Katarina Ludajic

      Affiliations

    • Division of Blood Group Serology, Medical University of Vienna, Austria
    • ,
  • Yesilda Balavarca

      Affiliations

    • Department of Genetic Epidemiology, University Medical Center, University of Goettingen, Germany
    • ,
  • Heike Bickeböller

      Affiliations

    • Department of Genetic Epidemiology, University Medical Center, University of Goettingen, Germany
    • ,
  • Agathe Rosenmayr

      Affiliations

    • Division of Blood Group Serology, Medical University of Vienna, Austria
    • ,
  • Gottfried F. Fischer

      Affiliations

    • Division of Blood Group Serology, Medical University of Vienna, Austria
    • Corresponding Author InformationCorrespondence and reprint requests: Gottfried F. Fischer, MD, Klinische Abteilung für Blutgruppenserologie, Medizinische Universitaet Wien, Waehringer Guertel 18-20, 1090 Vienna, Austria.
    • ,
  • Ingrid Faé

      Affiliations

    • Division of Blood Group Serology, Medical University of Vienna, Austria
    • ,
  • Peter Kalhs

      Affiliations

    • Department of Internal Medicine I, Bone Marrow Transplantation, Medical University of Vienna, Austria
    • ,
  • David Pohlreich

      Affiliations

    • Department of Internal Medicine I, Bone Marrow Transplantation, Medical University of Vienna, Austria
    • ,
  • Michal Kouba

      Affiliations

    • Department of Internal Medicine I, Bone Marrow Transplantation, Medical University of Vienna, Austria
    • ,
  • Marie Dobrovolna

      Affiliations

    • National Reference Laboratory for DNA Diagnostics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
    • ,
  • Hildegard T. Greinix

      Affiliations

    • Department of Internal Medicine I, Bone Marrow Transplantation, Medical University of Vienna, Austria

Received 12 December 2008 ,Accepted 6 July 2009.

References 

  1. Ottinger HD, Ferencik S, Beelen DW, et al. Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors. Blood. 2003;102:1131–1137
  2. Yakoub-Agha I, Mesnil F, Kuentz M, et al. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy. J Clin Oncol. 2006;24:5695–5702
  3. Goulmy E. Human minor histocompatibility antigens. Curr Opin Immunol. 1996;8:75–81
  4. Dickinson AM, Charron D. Non-HLA immunogenetics in hematopoietic stem cell transplantation. Curr Opin Immunol. 2005;17:517–525
  5. Goulmy E. Minor histocompatibility antigens: from transplantation problems to therapy of cancer. Hum Immunol. 2006;67:433–438
  6. Bignon JD, Gagne K. KIR matching in hematopoietic stem cell transplantation. Curr Opin Immunol. 2005;17:553–559
  7. Dickinson AM, Middleton PG, Rocha V, Gluckman E, Holler E. Genetic polymorphisms predicting the outcome of bone marrow transplants. Br J Haematol. 2004;127:479–490
  8. Petersdorf EW, Malkki M. Genetics of risk factors for graft-versus-host disease. Semin Hematol. 2006;43:11–23
  9. Szulman AE. The histological distribution of blood group substances A and B in man. J Exp Med. 1960;111:785–800
  10. Novaretti MC, Domingues AE, Manhani R, Pinto EM, Dorlhiac-Llacer PE, Chamone DA. ABO genotyping in leukemia patients reveals new ABO variant alleles. Genet Mol Res. 2008;7:87–94
  11. Eiz-Vesper B, Seltsam A, Blasczyk R. ABO glycosyltransferases as potential source of minor histocompatibility antigens in allogeneic peripheral blood progenitor cell transplantation. Transfusion. 2005;45:960–968
  12. Keever-Taylor CA, Bredeson C, Loberiza FR, et al. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Biol Blood Marrow Transplant. 2001;7:620–630
  13. Seebach JD, Stussi G, Passweg JR, et al. ABO blood group barrier in allogeneic bone marrow transplantation revisited. Biol Blood Marrow Transplant. 2005;11:1006–1013
  14. Stussi G, Seebach L, Muntwyler J, Schanz U, Gmur J, Seebach JD. Graft-versus-host disease and survival after ABO-incompatible allogeneic bone marrow transplantation: a single-centre experience. Br J Haematol. 2001;113:251–253
  15. Benjamin RJ, McGurk S, Ralston MS, Churchill WH, Antin JH. ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion. 1999;39:179–187
  16. Stussi G, Muntwyler J, Passweg JR, et al. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;30:87–93
  17. Goldman J, Liesveld J, Nichols D, Heal J, Blumberg N. ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation. Leuk Res. 2003;27:489–491
  18. Klumpp TR, Herman JH, Ulicny J, Emmons RV, Martin ME, Mangan KF. Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2006;38:615–620
  19. Mielcarek M, Leisenring W, Torok-Storb B, Storb R. Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect. Blood. 2000;96:1150–1156
  20. Erker CG, Steins MB, Fischer RJ, et al. The influence of blood group differences in allogeneic hematopoietic peripheral blood progenitor cell transplantation. Transfusion. 2005;45:1382–1390
  21. Wirk B, Klumpp TR, Ulicny J, et al. Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation. Transfusion. 2008;48:163–168
  22. Fischer GF, Fae I, Frey E, Mayr WR. HLA-A∗02172∗ adds to the heterogeneity of HLA-A∗02 alleles. Tissue Antigens. 1998;51:312–314
  23. Ludajic K, Balavarca Y, Bickeboller H, et al. Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT. Br J Haematol. 2008;142:436–443
  24. Widmann FK. Technical Manual of the American Association of Blood Banks. 9th ed. Arlington, VA: American Association of Blood Banks (AABB); 1985;
  25. Greinix HT, Fae I, Schneider B, et al. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors. Bone Marrow Transplant. 2005;35:57–62
  26. Bacigalupo A, Van Lint MT, Occhini D, Margiocco M, Ferrari G, Pittaluga PA, et al. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation. Transplantation. 1988;45:1091–1094
  27. den Haan JM, Meadows LM, Wang W, Pool J, Blokland E, Bishop TL, et al. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science. 1998;279:1054–1057
  28. Goulmy E. Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol Rev. 1997;157:125–140
  29. Dickinson AM, Wang XN, Sviland L, Vyth-Dreese FA, Jackson GH, Schumacher TN, et al. In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nat Med. 2002;8:410–414
  30. Worel N, Kalhs P, Keil F, Prinz E, Moser K, Schulenburg A, et al. ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation. Transfusion. 2003;43:1153–1161
  31. Worel N, Greinix HT, Keil F, Mitterbauer M, Lechner K, Fischer G, et al. Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning. Transfusion. 2002;42:1293–1301

 Financial disclosure: See Acknowledgments on page 1405.

PII: S1083-8791(09)00322-X

doi: 10.1016/j.bbmt.2009.07.002

Biology of Blood and Marrow Transplantation
Volume 15, Issue 11 , Pages 1400-1406 , November 2009

Article Tools

* Image Usage & Resolution